Gigantomastia during pregnancy: effect of a dopamine agonist.
D000328:Adult; D001707:Biopsy, Needle; D001941:Breast Diseases / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D001971:Bromocriptine / Q000627:therapeutic use*; D004958:Estradiol / Q000097:blood; D004967:Estrogens / Q000652:urine; D005260:Female; D006801:Humans; D010928:Placental Lactogen / Q000097:blood; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D011263:Pregnancy Trimester, Third; D011374:Progesterone / Q000097:blood; D011388:Prolactin / Q000097:blood; D000509:alpha-Fetoproteins / Q000378:metabolism
D004967:Estrogens; D000509:alpha-Fetoproteins; D001971:Bromocriptine; D011374:Progesterone; D004958:Estradiol; D011388:Prolactin; D010928:Placental Lactogen